Navigation Links
FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over
Date:2/11/2008

BOSTON, Feb. 11 /PRNewswire/ -- Replikins Ltd. announced that the quantitative analysis of Replikin Count(TM) in the virus gene structure predicts that the current H5N1 cycle is over. Sporadic outbreaks may continue, but the rapid epidemic spread and high mortality characteristics are expected to subside - until the next rapid replication cycle of this or another influenza virus strain begins.

140,000 virus protein sequences were analyzed by FluForecast(R) software in this study. A key gene, the Replikin Peak Gene, was found to contain the highest concentration of replikins in the virus genome. In H5N1 reservoirs in chickens, the Replikin Count(TM) has now decreased markedly, successively each year from 2004 to 2007. The Replikin count in human H5N1 also has decreased in the past year. All stated increases and decreases were statistically significant with a p value of less than 0.001.

The current H5N1 cycle of bird flu began in 1996 with a pre-symptomatic increase in the Replikin count, followed in 1997 by the Hong Kong outbreak, then by a decline in Replikin count in 1998-1999 with culling, followed by increases in the count in 2001 and 2004 providing advance warning of the further outbreaks which occurred in Asia. An increase in the Replikin count in human H5N1 in 2006 specifically predicted the increase in H5N1 lethality in humans, and that the first country to show this increase would be Indonesia. These predictions were proven correct in 2006-2007.

The last two influenza pandemics of 1957 (H2N2) and 1968 (H3N2), and the SARS outbreak of 2003, were also each preceded by an increase in the Replikin count, and in each case, a strain-specific decrease in the count several years later signaled that the cycle was over. Sporadic outbreaks of H3N2 for example have occurred thereafter, but the rapid epidemic spread and high mortality characteristics have not reappeared.

It has not been possible previously to predict in advance from changes in the structure of the virus the coming of epidemics or their cessation. This is now possible because of the discovery of the replikins, specific small peptide constituents of virus proteins whose concentration has been shown to be related quantitatively to rapid replication and epidemics.

FluForecast(R) is a product and service of Replikins Ltd. and Replikins, LLC, 38 The Fenway, Boston MA 02215. See also http://www.replikins.com.

Contact: sbogoch@replikins.com; Tel. 646-320-5910; 617-536-0220.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Lethal Human H5N1 Influenza Virus Replikin Gene Still Upregulated
2. DNA Predicts Reaction to Drug That Fights Alcohol Dependence
3. Multigene Test Predicts Who Could Avoid Chemotherapy Despite Positive Lymph Nodes in Early Breast Cancer
4. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
5. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
6. Pressure BioSciences, Inc. Announces CE Mark Approval and Compliance with the IEC 61010-1 Standard for a Second PCT-based Instrument, the Barocycler NEP2320
7. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
8. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon Hemopurifier® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... SAN DIEGO , Feb. 22, ... (OTCQB:CELZ) announced today expansion of its translational research ... product through establishment of laboratory facilities in San ... the San Diego BioLabs facility, a biotechnology incubator ... and Sanofi. In November 2016, the ...
(Date:2/21/2017)... Feb. 21, 2017 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the ... results for the three months ended December 31, 2016. ... life sciences and diagnostics company that develops and commercializes proprietary ... ... build on the commercial milestones achieved in fiscal 2016," said ...
(Date:2/21/2017)... Basel, Switzerland (PRWEB) , ... February 21, 2017 ... ... for biopharmaceutical and biotech research and development (R&D), today announced the establishment of ... headed by Managing Director Kevin Teburi, a recognized expert in life science informatics. ...
Breaking Biology Technology:
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:1/30/2017)...   Invitae Corporation (NYSE: NVTA ... today announced that it will report its fourth quarter ... on Monday, February 13, 2017, and Invitae,s management team ... p.m. Eastern / 1:45 p.m. Pacific. ... financial results, guidance, and recent developments and will spend ...
(Date:1/24/2017)... PHILADELPHIA , Jan. 24, 2017  It ... a baby,s sock that monitors vital signs and ... instance, an infant,s oxygen saturation level drops. But ... undue alarm to parents, with no evidence of ... "These devices are marketed aggressively to parents of ...
Breaking Biology News(10 mins):